Company Update Marksans Pharma Ltd - 524404 - Announcement under Regulation 30 (LODR)-Press Release / Media Release BSE India Marksans Pharma Limited''s wholly owned subsidiary Relonchem Limited receives Marketing Authorisation for its products from UK MHRA.